A new study reveals that the abortion pill mifepristone carries a rate of serious or life-threatening complications 22 times higher than what the U.S. Food and Drug Administration (FDA) and the drug’s manufacturer, Danco Laboratories, have claimed.
In 2021, the Biden administration relaxed regulations, permanently allowing the dangerous abortion drug to be dispensed via mail and permitting pharmacies like Walgreens and CVS to distribute it. The FDA also reduced oversight, eliminating requirements for prescribers to report non-fatal adverse events unless a patient dies. Women can now obtain mifepristone through a single telehealth visit and self-administer it without in-person medical supervision. The study warns that this lack of oversight increases the likelihood of undetected complications, such as ectopic pregnancies, which can be life-threatening. Read the full article below.